Anti-RNF5/ RING5/ RMA1 monoclonal antibody

Anti-RNF5/ RING5/ RMA1 antibody for FACS & in-vivo assay

Target products collectionGo to RNF5/RNF5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1466-Ab-1/ GM-Tg-hg-MP1466-Ab-2Anti-Human RNF5 monoclonal antibodyHuman
GM-Tg-rg-MP1466-Ab-1/ GM-Tg-rg-MP1466-Ab-2Anti-Rat RNF5 monoclonal antibodyRat
GM-Tg-mg-MP1466-Ab-1/ GM-Tg-mg-MP1466-Ab-2Anti-Mouse RNF5 monoclonal antibodyMouse
GM-Tg-cynog-MP1466-Ab-1/ GM-Tg-cynog-MP1466-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1466-Ab-1/ GM-Tg-felg-MP1466-Ab-2Anti-Feline RNF5 monoclonal antibodyFeline
GM-Tg-cang-MP1466-Ab-1/ GM-Tg-cang-MP1466-Ab-2Anti-Canine RNF5 monoclonal antibodyCanine
GM-Tg-bovg-MP1466-Ab-1/ GM-Tg-bovg-MP1466-Ab-2Anti-Bovine RNF5 monoclonal antibodyBovine
GM-Tg-equg-MP1466-Ab-1/ GM-Tg-equg-MP1466-Ab-2Anti-Equine RNF5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1466-Ab-1/ GM-Tg-hg-MP1466-Ab-2; GM-Tg-rg-MP1466-Ab-1/ GM-Tg-rg-MP1466-Ab-2;
GM-Tg-mg-MP1466-Ab-1/ GM-Tg-mg-MP1466-Ab-2; GM-Tg-cynog-MP1466-Ab-1/ GM-Tg-cynog-MP1466-Ab-2;
GM-Tg-felg-MP1466-Ab-1/ GM-Tg-felg-MP1466-Ab-2; GM-Tg-cang-MP1466-Ab-1/ GM-Tg-cang-MP1466-Ab-2;
GM-Tg-bovg-MP1466-Ab-1/ GM-Tg-bovg-MP1466-Ab-2; GM-Tg-equg-MP1466-Ab-1/ GM-Tg-equg-MP1466-Ab-2
Products NameAnti-RNF5 monoclonal antibody
Formatmab
Target NameRNF5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RNF5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species RNF5/ RING5/ RMA1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP003006human RNF5 Lentivirus plasmid
    ORF Viral VectorvGMLP003006human RNF5 Lentivirus particle
    ORF Viral VectorpGMLPm002577mouse Rnf5 Lentivirus plasmid
    ORF Viral VectorvGMLPm002577mouse Rnf5 Lentivirus particle


    Target information

    Target IDGM-MP1466
    Target NameRNF5
    Gene ID6048,54197,407784,717234,474858,101096477,616187,100051626
    Gene Symbol and Synonyms2410131O05Rik,NG2,RING5,RMA1,RNF5
    Uniprot AccessionQ99942,Q5M807
    Uniprot Entry NameRNF5_HUMAN,RNF5_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000204308
    Target ClassificationN/A

    The target: RNF5, gene name: RNF5, also named as RING5, RMA1. The protein encoded by this gene contains a RING finger, which is a motif known to be involved in protein-protein interactions. This protein is a membrane-bound ubiquitin ligase. It can regulate cell motility by targeting paxillin ubiquitination and altering the distribution and localization of paxillin in cytoplasm and cell focal adhesions. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.